Vaccine Type: Non Replicating Viral Vector
This vaccine may also be referred to as Gam-COVID-Vac
This vaccine is approved.
About Trial Phases
Total Enrollment: 6,000
Total Enrollment: 110
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form